Biology:Excitatory amino acid transporter 1

From HandWiki
Short description: Protein found in humans


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example


Excitatory amino acid transporter 1 (EAAT1) is a protein that, in humans, is encoded by the SLC1A3 gene.[1] EAAT1 is also often called the GLutamate ASpartate Transporter 1 (GLAST-1).

EAAT1 is predominantly expressed in the plasma membrane, allowing it to remove glutamate from the extracellular space.[2] It has also been localized in the inner mitochondrial membrane as part of the malate-aspartate shuttle.[3]

Mechanism

EAAT1 functions in vivo as a homotrimer.[4] EAAT1 mediates the transport of glutamic and aspartic acid with the cotransport of three Na+ and one H+ cations and counter transport of one K+ cation. This co-transport coupling (or symport) allows the transport of glutamate into cells against a concentration gradient.[5]

Tissue distribution

EAAT1 is expressed throughout the CNS,[6] and is highly expressed in astrocytes and Bergmann glia in the cerebellum.[7][8] In the retina, EAAT1 is expressed in Muller cells.[9] EAAT1 is also expressed in a number of other tissues including cardiac myocytes.[3]

Clinical significance

It is associated with type 6 episodic ataxia.[10] EAAT1 expression may also be associated with osteoarthritis.[11]

Pharmacology

DL-threo-beta-benzyloxyaspartate (TBOA) is an inhibitor of the excitatory amino acid transporters.[12]

Selective inhibitors for EAAT1 have recently been discovered based on 25 combinations of substitutions at the 4 and 7 positions of 2-amino-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitril.[13]

References

  1. "Entrez Gene: SLC1A3 solute carrier family 1 (glial high affinity glutamate transporter), member 3". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=6507. 
  2. "Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations". The Journal of Neuroscience 15 (3 Pt 1): 1835–53. March 1995. doi:10.1523/JNEUROSCI.15-03-01835.1995. PMID 7891138. 
  3. 3.0 3.1 "Localization and function of the brain excitatory amino acid transporter type 1 in cardiac mitochondria". Journal of Molecular and Cellular Cardiology 37 (1): 33–41. July 2004. doi:10.1016/j.yjmcc.2004.04.008. PMID 15242733. 
  4. "A trimeric quaternary structure is conserved in bacterial and human glutamate transporters". The Journal of Biological Chemistry 279 (38): 39505–12. September 2004. doi:10.1074/jbc.M408038200. PMID 15265858. 
  5. "The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects". Pflügers Archiv 447 (5): 469–79. February 2004. doi:10.1007/s00424-003-1146-4. PMID 14530974. 
  6. "Glutamate uptake". Progress in Neurobiology 65 (1): 1–105. September 2001. doi:10.1016/S0301-0082(00)00067-8. PMID 11369436. 
  7. "Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain". Proceedings of the National Academy of Sciences of the United States of America 89 (22): 10955–9. November 1992. doi:10.1073/pnas.89.22.10955. PMID 1279699. Bibcode1992PNAS...8910955S. 
  8. "Localization of neuronal and glial glutamate transporters". Neuron 13 (3): 713–25. September 1994. doi:10.1016/0896-6273(94)90038-8. PMID 7917301. 
  9. "High-affinity glutamate transporters in the rat retina: a major role of the glial glutamate transporter GLAST-1 in transmitter clearance". Cell and Tissue Research 291 (1): 19–31. January 1998. doi:10.1007/s004410050976. PMID 9394040. 
  10. "Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures". Neurology 65 (4): 529–34. August 2005. doi:10.1212/01.WNL.0000172638.58172.5a. PMID 16116111. 
  11. "Expression of glutamate receptors and transporters in human subchondral bone in osteoarthritis". Orthopaedic Proceedings (The British Editorial Society of Bone & Joint Surgery) 93-B (SUPP_I): 411. July 2010. doi:10.1302/0301-620X.93BSUPP_I.0930069b. https://online.boneandjoint.org.uk/doi/abs/10.1302/0301-620X.93BSUPP_I.0930069b. 
  12. "DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters". Molecular Pharmacology 53 (2): 195–201. February 1998. doi:10.1124/mol.53.2.195. PMID 9463476. 
  13. "Discovery of the first selective inhibitor of excitatory amino acid transporter subtype 1". Journal of Medicinal Chemistry 52 (4): 912–5. February 2009. doi:10.1021/jm8013458. PMID 19161278. 

Further reading

External links